ValleyDAO is a decentralized platform revolutionizing funding and translation for synthetic biology research to combat climate change.
Accelerating a cure for 100M Long COVID patients.
The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model.
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief.
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT.
ValleyDAO
Long Covid Labs
Neuron-Gale
Relieva
eDMT Commons
0.13%
